Sites not expected to fade away even as DCTs continue to grow past COVID-19.
William Chaplin
Advertisement
William Chaplin is a consultant for ZS's R&D excellence team and member of the digital and DCT vertical in clinical development.
Articles by William Chaplin
Identifying and providing clarity on the GCP quality and risk concerns associated with DCT modalities.
Assessing the opportunities, considerations and implications of decentralized trials—and why they’re here to stay
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
2025 SCRS Global Site Solutions Summit: How Technology Vendors Can Reduce Site Burden and Improve Trial Execution
3
2025 SCRS Global Site Solutions Summit: How to Streamline Site Qualification and Initiation Training
4
AI Everywhere: Architecting the Future of Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
